MAPKAP kinases MK2 and MK3 in inflammation: Complex regulation of TNF biosynthesis via expression and phosphorylation of tristetraprolin
- 1 December 2010
- journal article
- review article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 80 (12), 1915-1920
- https://doi.org/10.1016/j.bcp.2010.06.021
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft
- Hannover Biomedical Research School
This publication has 59 references indexed in Scilit:
- Tristetraprolin Mediates Interferon-γ mRNA DecayJournal of Biological Chemistry, 2009
- p38α MAPK inhibits JNK activation and collaborates with IκB kinase 2 to prevent endotoxin‐induced liver failureEMBO Reports, 2008
- Genome-wide Analysis Identifies Interleukin-10 mRNA as Target of TristetraprolinJournal of Biological Chemistry, 2008
- p38α suppresses normal and cancer cell proliferation by antagonizing the JNK–c-Jun pathwayNature Genetics, 2007
- Molecular basis of MAPK-activated protein kinase 2:p38 assemblyProceedings of the National Academy of Sciences, 2007
- TTP and BRF proteins nucleate processing body formation to silence mRNAs with AU-rich elementsGenes & Development, 2007
- The Mitogen-Activated Protein Kinase (MAPK)-Activated Protein Kinases MK2 and MK3 Cooperate in Stimulation of Tumor Necrosis Factor Biosynthesis and Stabilization of p38 MAPKMolecular and Cellular Biology, 2007
- Novel mRNA Targets for Tristetraprolin (TTP) Identified by Global Analysis of Stabilized Transcripts in TTP-Deficient FibroblastsMolecular and Cellular Biology, 2006
- MAPKAP Kinase 2 Phosphorylates Tristetraprolin on in Vivo Sites Including Ser178, a Site Required for 14-3-3 BindingJournal of Biological Chemistry, 2004
- Deficiency of the Stress Kinase P38α Results in Embryonic LethalityThe Journal of Experimental Medicine, 2000